Codes / ICD10CM / O28.2

O28.2 Abnormal cytological finding on antenatal screening of mother

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Abnormal cytological finding on antenatal screening of mother
  • ICD-10 Code: O28.2

Summary

This condition refers to atypical or unexpected results from cytological screening tests performed during pregnancy to assess maternal or fetal health. These findings may indicate potential concerns that require further evaluation to determine their significance and guide appropriate management.

Causes

Abnormal cytological findings are not a condition with direct causes. They serve as indicators that there may be underlying issues, such as genetic variations, fetal development abnormalities, or maternal health factors, which necessitate additional investigation to clarify their impact.

Risk Factors

  • Advanced maternal age
  • Pre-existing maternal health conditions (e.g., diabetes, hypertension)
  • Family history of genetic disorders or birth defects
  • Previous pregnancy complications
  • Exposure to certain substances or medications during pregnancy

Symptoms

This diagnosis is typically identified through screening tests and may not present symptoms directly noticeable by the patient. Any associated symptoms would depend on the underlying cause of the abnormal finding.

Diagnosis

Diagnosis is made through various antenatal screening methods, such as cytological tests (e.g., Pap smears, cervical screening), blood tests, or other specialized evaluations. Abnormal results may prompt further testing, including imaging or genetic analysis, to determine the cause and significance.

Treatment Options

Treatment depends on the specific underlying issue detected. Options may include:

  • Close monitoring and follow-up screenings
  • Consultation with specialists, such as a maternal-fetal medicine doctor
  • Interventions tailored to the identified concern (e.g., medication, lifestyle adjustments)

Prognosis and Follow-Up

The prognosis varies based on the underlying cause of the abnormal finding. Regular follow-up is essential to monitor the pregnancy and address any evolving concerns. Early detection and appropriate management can improve outcomes for both mother and fetus.

Complications

Potential complications depend on the underlying issue but may include:

  • Increased risk of pregnancy-related complications
  • Need for additional interventions or procedures
  • Emotional or psychological stress related to uncertainty

Lifestyle & Prevention

  • Maintain regular prenatal care to ensure timely screening and monitoring
  • Follow recommended health guidelines during pregnancy
  • Discuss any concerns or symptoms with a healthcare provider promptly

When to Seek Professional Help

Seek medical attention if you experience unusual symptoms (e.g., bleeding, pain) or have concerns about your pregnancy. Prompt evaluation of abnormal screening results is critical for appropriate management.

Tips for Medical Coders

Document the specific cytological finding and any follow-up actions taken. Ensure the code O28.2 is used when the abnormality is identified through cytological screening and no more specific code applies. Include details about the screening method and any additional testing performed to support clinical decision-making.

Book a walkthrough

O28.2 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.